iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Trading Up 0.7% – Should You Buy?

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)’s share price traded up 0.7% during trading on Monday . The stock traded as high as $23.14 and last traded at $22.91. 61,518 shares were traded during mid-day trading, an increase of 106% from the average session volume of 29,814 shares. The stock had previously closed at $22.74.

iShares Genomics Immunology and Healthcare ETF Stock Down 0.0 %

The company’s fifty day moving average is $22.72 and its 200 day moving average is $23.79. The stock has a market cap of $134.55 million, a PE ratio of 2.29 and a beta of 1.14.

Institutional Trading of iShares Genomics Immunology and Healthcare ETF

A hedge fund recently bought a new stake in iShares Genomics Immunology and Healthcare ETF stock. Avior Wealth Management LLC acquired a new position in shares of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 9,500 shares of the company’s stock, valued at approximately $234,000. Avior Wealth Management LLC owned about 0.16% of iShares Genomics Immunology and Healthcare ETF as of its most recent filing with the Securities and Exchange Commission.

iShares Genomics Immunology and Healthcare ETF Company Profile

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.